Purple Biotech Ltd - ADR
PPBT
Market Cap$6.49M
Close$
$0.21
91.4% downside
Current Fair Value
91.4% downsideOvervalued by 91.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.49 Million |
|---|---|
| Enterprise Value | $6.49 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.03 |
| Beta | -0.74 |
| Outstanding Shares | 2,650,684 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.43 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Purple Biotech Ltd
CEO: Itzhak Israel